
APDN Announces Closing of $12M Upsized Public Offering
August 8th, 2022
APDN Announces Closing of $12M Upsized Public Offering
August 8th, 2022
APDN Announces Pricing of $12M Upsized Public Offering
August 4th, 2022
Applied DNA Reports Second Quarter Fiscal 2022 Financial Results
May 12th, 2022
APDN Schedules FY’22 Q2 Results Conference Call & Webcast
May 9th, 2022
Applied DNA to Participate in 2022 Maxim Virtual Growth Conference
March 23rd, 2022
Applied DNA Announces Closing of $4.2 Million Registered Direct Offering
February 25th, 2022
APDN Announces Pricing of $4.2 Million Registered Direct Offering
February 22nd, 2022
APDN FQ1’22 Financial Results Feature Record Quarterly Revenues
February 10th, 2022
APDN Schedules FQ1’22 Financial Results Call and Webcast
February 3rd, 2022